C07C 65/10
Salicylic acid
C07C65/10 (Salicylic acid) appears on 76 US grants and 89 published applications in this corpus.
Search patents in C07C- Granted patents
- 76
- Published applications
- 89
- Assignees
- 74
- Inventors
- 327
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 2 | 6 |
| 2013 | 4 | 4 |
| 2014 | 2 | 1 |
| 2015 | 4 | 3 |
| 2016 | 2 | 4 |
| 2017 | 6 | 7 |
| 2018 | 3 | 7 |
| 2019 | 3 | 3 |
| 2020 | 3 | 2 |
| 2021 | 2 | 6 |
| 2022 | 4 | 8 |
| 2023 | 4 | 9 |
| 2024 | 5 | 11 |
| 2025 | 3 | 5 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Combination product comprising dicycloplatin and preparation method and use thereof26 May 2026US 12,637,487 B2Medoncare Pharmaceutical Co., Ltd.
- Salts and crystal forms of omecamtiv mecarbil28 Apr 2026US 12,612,366 B2Amgen Inc.
- Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same17 Feb 2026US 12,552,737 B2The United States Government as represented by the Department of Veterans Affairs
- Salts of an FGFR inhibitor18 Nov 2025US 12,473,286 B2Incyte Corporation
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
- Cocrystals of cortexolone 17-propionate and methods for their preparation6 Aug 2026US 2026/0226092 A1Farmabios S.P.A.
- Salts of an fgfr inhibitor16 Apr 2026US 2026/0103467 A1Incyte Corporation
- Ionic Derivatives Of Aromatic Carboxylic Acid For Use As Plant Stimulants, Method For Stimulating Plants And Use Of These Derivatives For Manufacturing Compositions For Stimulating Plants12 Feb 2026US 2026/0041093 A1Fundacja Uniwersytetu Im. Adama Mickiewicza W Poznaniu
- Method for producing lactide complex22 Jan 2026US 2026/0022106 A1Lamacics Co., Ltd.
Most cited
By later US patents
- Salt forms of a xanthine compound44US 8,865,729 B2Boehringer Ingelheim International GmbH · 2014
- Water soluble salts of an NSAID with meglumine/glucamine39US 4,748,174 ATherapicon SRL · 1988
- Lipophilic quaternary ammonium salicylates, their use in cosmetics and in dermopharmacy38US 5,001,156 AL'oreal · 1991
- Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine34US 9,212,183 B2Boehringer Ingelheim International GmbH · 2015
- Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them28US 5,360,925 ASociete de Conseils de Recherches et d' Applications Scientifiques · 1994